(Q50789392)

19 March 2018

title

Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy. (English)

1 reference

19 March 2018

author

Daniel A. Lawrence

6

1 reference

19 March 2018

author name string

Crandall DL

1

1 reference

19 March 2018

Elokdah H

2

1 reference

19 March 2018

Di L

3

1 reference

19 March 2018

Hennan JK

4

1 reference

19 March 2018

Gorlatova NV

5

1 reference

19 March 2018

publication date

1 August 2004

1 reference

19 March 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

19 March 2018

volume

2

1 reference

19 March 2018

issue

8

1 reference

19 March 2018

page(s)

1422-1428

1 reference

19 March 2018

Course of molecular hemostatic markers during and after different surgical procedures.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Effects of ximelagatran, the oral form of melagatran, in the treatment of caval vein thrombosis in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparin in a rat model of arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00829.X

10.1111/J.1538-7836.2004.00829.X

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

PubMed ID

15304050

1 reference

19 March 2018